Healthcare seed funding share drops 3pp while AI & Data rises 3.6pp in France and Netherlands
- Healthcare & Life Sciences seed share fell 3 percentage points from 2021 to 2024
- Artificial Intelligence & Data seed share rose 3.6 percentage points over the same period
- Healthcare median seed round (€10.3M) remains slightly above AI median (€9.6M)
Across the 1,500 seed-stage deals Brouky tracks in France and the Netherlands, Healthcare & Life Sciences experienced the largest decline in funding share between 2021 and 2024, dropping 3 percentage points from 14.9% to 11.9%. This contraction contrasts with the growth of the Artificial Intelligence & Data sector, which gained 3.6 percentage points, increasing its share from 8.6% to 12.2%. This may partly reflect expanding data coverage.
Despite losing share, Healthcare rounds maintain a higher median size of €10,295,872 compared to AI & Data's median of €9,587,156, indicating sustained investor confidence in later-stage capital intensity within healthcare.
MEDIAN SEED ROUND SIZE BY SECTOR (EUR)
Other sectors such as Software & Developer Tools also showed notable gains (+10.8pp), but the most direct substitution observed is between Healthcare's retreat and AI & Data's rise. This reflects evolving investor priorities in early-stage ventures within these two countries.
Related insights
- Cross-Country AnalysisHealthcare's 2pp funding share decline contrasts with Industry's 1.5pp rise in France and Spain
- Stage AnalysisSeries A median round size in Switzerland rose 40% from 2024 to 2025
- Deal SpotlightIsometric raises EUR43M Series A with B Y Venture Partners, Dubai Future District Fund, and others
- Deal SpotlightEuclyd raises EUR200M Series A backed by Brabant Development Agency, imec.xpand and others
Explore the full dataset
Brouky tracks 36,000+ investors and 100,000+ investments across 84,000+startups. Search by country, stage, and sector.